Back to video list Back to Home How would you choose which CGRP pathway monoclonal antibody medication is for which patient and how do you convince the patient to be on eptinezumab? You may also like Alzheimer's Disease Congress highlights Article Highlights in Alzheimer’s disease research from AAN Virtual 2022 Schizophrenia Satellite symposium Article Why patients with schizophrenia do not socially engage? Mental Health Article Socioeconomic inequality: a determinant in mental health disorders? Schizophrenia Satellite symposium Article Cognitive impairment, as a key symptom of schizophrenia